411210-92-9 Usage
Uses
Used in Pharmaceutical Industry:
5-Chloro-2-cyanobenzene-1-sulfonyl chloride is used as a versatile intermediate for the synthesis of various pharmaceutical products. Its unique structural features and chemical reactivity make it an important reagent in the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, 5-Chloro-2-cyanobenzene-1-sulfonyl chloride is utilized as a key building block in the preparation of sulfonylurea herbicides. Its role in the synthesis of these herbicides contributes to the development of effective and environmentally friendly weed control solutions.
Used in Material Science:
5-Chloro-2-cyanobenzene-1-sulfonyl chloride is also employed in material science, where its versatile chemical properties and unique structural features are harnessed for the synthesis of complex organic molecules with potential applications in various fields, such as polymers, dyes, and other specialty chemicals.
Overall, 5-Chloro-2-cyanobenzene-1-sulfonyl chloride is a crucial compound in the fields of medicinal chemistry, agrochemicals, and material science, owing to its diverse applications and the potential for further research and development in these areas.
Check Digit Verification of cas no
The CAS Registry Mumber 411210-92-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,1,2,1 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 411210-92:
(8*4)+(7*1)+(6*1)+(5*2)+(4*1)+(3*0)+(2*9)+(1*2)=79
79 % 10 = 9
So 411210-92-9 is a valid CAS Registry Number.
411210-92-9Relevant academic research and scientific papers
HETEROCYCLIC COMPOUND
-
Paragraph 0965; 0966, (2019/06/17)
Provided is a heterocyclic compound that may have a GCN2 inhibitory action, and is expected to be useful for the prophylaxis or treatment of GCN2 associated diseases including cancer and the like. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
ORGANIC COMPOUNDS
-
Page/Page column 81, (2010/02/15)
There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives
Masuda, Naoyuki,Yamamoto, Osamu,Fujii, Masahiro,Ohgami, Tetsuro,Fujiyasu, Jiro,Kontani, Toru,Moritomo, Ayako,Orita, Masaya,Kurihara, Hiroyuki,Koga, Hironobu,Kageyama, Shunji,Ohta, Mitsuaki,Inoue, Hiroshi,Hatta, Toshifumi,Shintani, Masafumi,Suzuki, Hiroshi,Sudo, Kenji,Shimizu, Yasuaki,Kodama, Eiichi,Matsuoka, Masao,Fujiwara, Masatoshi,Yokota, Tomoyuki,Shigeta, Shiro,Baba, Masanori
, p. 949 - 961 (2007/10/03)
In a previous study, we described the structure-activity relationships (SARs) for a series of thiazolidenebenzenesulfonamide derivatives. These compounds were found to be highly potent inhibitors of the wild type (WT) and Y181C mutant reverse transcriptas
